Fig. 1

Long-term survival after autologous stem-cell transplantation (ASCT): a overall survival and non-relapse mortality, b overall survival by harvest yield in millions of CD34⁺ cells/kg patient (with bone-marrow harvested patients included as a separate category) and, c overall survival using the 5 million CD34⁺ cells/kg patient cut point